LivaNova PLC (LIVN):医療機器:M&Aディール及び事業提携情報

◆英語タイトル:LivaNova PLC (LIVN) - Medical Equipment - Deals and Alliances Profile
◆商品コード:DATA904C7888
◆発行会社(調査会社):GlobalData
◆発行日:2018年10月
◆ページ数:52
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:イギリス
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
LivaNova PLC (LivaNova) is a medical technology company that offers medical devices for cardiac surgery and neuromodulation. The company’s neuromodulation provides vagus nerve stimulation therapy system, an implantable device for the people affected by treatment-resistant epilepsy, depression, heart failure and other chronic disorders. Its cardiovascular surgery products include oxygenators, heart-lung machines, perfusion tubing systems, cannulae and accessories; systems for auto transfusion and autologous blood washing; surgical tissue and mechanical valve replacements, and repair products for damaged or diseased heart valves. The company offers its solutions to patients, healthcare professionals and healthcare systems. LivaNova is headquartered in London, England, the UK.

LivaNova PLC (LIVN) – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 5
List of Figures 5
LivaNova PLC , Medical Equipment, Deals By Year, 2012 to YTD 2018 6
LivaNova PLC , Medical Equipment Deals By Type, 2012 to YTD 2018 7
LivaNova PLC , Medical Equipment, Deals By Region, 2012 to YTD 2018 8
LivaNova PLC , Medical Equipment, Deals By Market, 2012 to YTD 2018 9
LivaNova PLC , Medical Equipment, Deals Summary, 2012 to YTD 2018 10
LivaNova PLC , Medical Equipment, Deal Details 11
Venture Financing 11
Ceribell Raises USD35 Million in Series B Financing 11
HighLife Raises USD12.3 Million in Venture Financing 12
MD Start Secures USD11.5 Million in Venture Funding 13
Private Equity 14
MicroPort Scientific and Yunfeng Capital Acquire Cardiac Rhythm Management Business from LivaNova For USD190 Million 14
Partnerships 16
Cyberonics Enters Into Licensing Agreement With Imricor Medical Systems For Novel MRI Compatibility Lead Technology 16
Merger 17
Sorin Merges with Cyberonics for USD2.7 Billion 17
Acquisition 19
LivaNova Acquires CardiacAssist 19
LivaNova Acquires Remaining Interest in ImThera Medical for up to USD225 Million 20
LivaNova Acquires Remaining 51% Stake in Caisson Interventional 21
Mittel Plans to Sell 6% Interest in LivaNova 22
NorthCoast Asset Management Divests Stake in Cyberonics 23
Cyberonics Acquires Minority Stake In cerbomed, Provider Of Neuro-Therapy Solutions, For US$2.6 Million 24
LivaNova PLC – Key Competitors 25
LivaNova PLC – Key Employees 26
LivaNova PLC – Locations And Subsidiaries 27
Head Office 27
Other Locations & Subsidiaries 27
Recent Developments 28
Strategy And Business Planning 28
Feb 07, 2018: Caisson Interventional Expanding in Maple Grove 28
Financial Announcements 29
Aug 01, 2018: LivaNova Reports Second Quarter 2018 Results 29
Feb 28, 2018: LivaNova Announces Fourth Quarter and Full-Year 2017 Results 31
Nov 02, 2017: LivaNova Reports Third Quarter 2017 Results 33
Aug 09, 2017: LivaNova Reports Second Quarter 2017 Results 35
May 03, 2017: LivaNova Reports First Quarter 2017 Results 37
Mar 31, 2017: LivaNova Reiterates Full-Year 2017 Guidance 39
Mar 01, 2017: LivaNova Reports Fourth Quarter and Full-Year 2016 Results 40
Corporate Communications 43
Jun 13, 2018: LivaNova Welcomes William Kozy to Board of Directors 43
Jan 08, 2018: LivaNova Announces Matthew J. Dodds as Senior Vice President, Corporate Development 44
Jun 12, 2017: LivaNova Appoints Keyna Skeffington as Senior Vice President and General Counsel 45
May 16, 2017: LivaNova Announces Thad Huston as Chief Financial Officer 46
Mar 31, 2017: LivaNova Announces Chief Financial Officer Resignation 47
Legal and Regulatory 48
Jun 21, 2017: VNS Therapy Receives FDA Approval for Expanded MRI Labeling 48
Feb 23, 2017: LivaNova Announces Its Intent to Delist from London Stock Exchange 49
Other Significant Developments 50
Sep 14, 2017: LivaNova to Explore Strategic Options for Cardiac Rhythm Management Business Franchise 50
Aug 07, 2017: LivaNova Implements 3T Heater-Cooler Device Modification 51
Appendix 52
Methodology 52
About GlobalData 52
Contact Us 52
Disclaimer 52

List of Tables
LivaNova PLC , Medical Equipment, Key Facts, 2017 2
LivaNova PLC , Medical Equipment, Deals Summary, 2012 to YTD 2018 2
LivaNova PLC , Medical Equipment, Deals By Year, 2012 to YTD 2018 6
LivaNova PLC , Medical Equipment Deals By Type, 2012 to YTD 2018 7
LivaNova PLC , Medical Equipment, Deals By Region, 2012 to YTD 2018 8
LivaNova PLC , Deals By Market, 2012 to YTD 2018 9
LivaNova PLC , Medical Equipment, Deals Summary, 2012 to YTD 2018 10
Ceribell Raises USD35 Million in Series B Financing 11
HighLife Raises USD12.3 Million in Venture Financing 12
MD Start Secures USD11.5 Million in Venture Funding 13
MicroPort Scientific and Yunfeng Capital Acquire Cardiac Rhythm Management Business from LivaNova For USD190 Million 14
Cyberonics Enters Into Licensing Agreement With Imricor Medical Systems For Novel MRI Compatibility Lead Technology 16
Sorin Merges with Cyberonics for USD2.7 Billion 17
LivaNova Acquires CardiacAssist 19
LivaNova Acquires Remaining Interest in ImThera Medical for up to USD225 Million 20
LivaNova Acquires Remaining 51% Stake in Caisson Interventional 21
Mittel Plans to Sell 6% Interest in LivaNova 22
NorthCoast Asset Management Divests Stake in Cyberonics 23
Cyberonics Acquires Minority Stake In cerbomed, Provider Of Neuro-Therapy Solutions, For US$2.6 Million 24
LivaNova PLC , Key Competitors 25
LivaNova PLC , Key Employees 26
LivaNova PLC , Subsidiaries 27

List of Figures
LivaNova PLC , Medical Equipment, Deals by Type, 2012 to YTD 2018 2
LivaNova PLC , Medical Equipment, Deals By Year, 2012 to YTD 2018 2
LivaNova PLC , Medical Equipment, Deals By Region, 2012 to YTD 2018 2
LivaNova PLC , Medical Equipment, Deals By Market, 2012 to YTD 2018 2
LivaNova PLC , Medical Equipment, Deals By Year, 2012 to YTD 2018 6
LivaNova PLC , Medical Equipment, Deals by Type, 2012 to YTD 2018 7
LivaNova PLC , Medical Equipment, Deals By Region, 2012 to YTD 2018 8
LivaNova PLC , Medical Equipment, Deals by Market, 2012 to YTD 2018 9

★海外企業調査レポート[LivaNova PLC (LIVN):医療機器:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Movado Group, Inc. (MOV):企業の財務・戦略的SWOT分析
    Movado Group, Inc. (MOV) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • Ridley Corporation Ltd:企業の戦略・SWOT・財務情報
    Ridley Corporation Ltd - Strategy, SWOT and Corporate Finance Report Summary Ridley Corporation Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • Trina Solar Co Ltd:企業の戦略的SWOT分析
    Trina Solar Co Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and ser …
  • The Cheesecake Factory Incorporated:企業の戦略・SWOT・財務情報
    The Cheesecake Factory Incorporated - Strategy, SWOT and Corporate Finance Report Summary The Cheesecake Factory Incorporated - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, …
  • Constant Contact, Inc.:企業の戦略・SWOT・財務分析
    Constant Contact, Inc. - Strategy, SWOT and Corporate Finance Report Summary Constant Contact, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • Knight Therapeutics Inc (GUD):企業の財務・戦略的SWOT分析
    Summary Knight Therapeutics Inc (Knight Therapeutics) focuses on acquisition, licensing, marketing and distribution of prescription, consumer health products and medical devices. The company offers tablets to treat metabolic, renal diseases and cancer; and injections against chronic pain and hormone …
  • Pacific Mutual Holding Company:企業の戦略的SWOT分析
    Pacific Mutual Holding Company - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major prod …
  • BNP Paribas SA:企業の戦略・SWOT・財務情報
    BNP Paribas SA - Strategy, SWOT and Corporate Finance Report Summary BNP Paribas SA - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpora …
  • Karur Vysya Bank Ltd:企業の戦略・SWOT・財務情報
    Karur Vysya Bank Ltd - Strategy, SWOT and Corporate Finance Report Summary Karur Vysya Bank Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • Aequus Pharmaceuticals Inc (AQS):企業の財務・戦略的SWOT分析
    Summary Aequus Pharmaceuticals Inc (Aequus Pharmaceuticals) is a drug discovery and development company that develops differentiated drugs. The company’s pipeline products include AQS304 finds application in the treatment of neurological disorders, and AQS303 is used for the treatment of treatment o …
  • The Toyama Bank, Ltd.:企業の戦略・SWOT・財務情報
    The Toyama Bank, Ltd. - Strategy, SWOT and Corporate Finance Report Summary The Toyama Bank, Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • Ohio State University Comprehensive Cancer Center-製薬・医療分野:企業M&A・提携分析
    Summary Ohio State University Comprehensive Cancer Center (OSUCCC), a subsidiary of Ohio State University is a healthcare institution that provides medical and academic education services. The institute provides education, research, and patient care services. Its service portfolio includes cancer di …
  • Santee Cooper:企業の戦略的SWOT分析
    Santee Cooper - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services …
  • Vitasoy International Holdings Ltd (0345):企業の財務・戦略的SWOT分析
    Vitasoy International Holdings Ltd (0345) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strength …
  • Suntory Beverage & Food Limited:企業の戦略・SWOT・財務分析
    Suntory Beverage & Food Limited - Strategy, SWOT and Corporate Finance Report Summary Suntory Beverage & Food Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product …
  • Bio-Path Holdings Inc (BPTH):企業の財務・戦略的SWOT分析
    Summary Bio-Path Holdings Inc (Bio-Path) is a clinical stage biotechnology company that develops targeted therapies for acute myeloid leukemia (AML), chronic myeloid leukemia (CML) and other challenging cancers. The company provides products pipeline such as prexigebersen (Liposomal Grb2 Antisense) …
  • McKesson Corporation:企業の戦略・SWOT・財務情報
    McKesson Corporation - Strategy, SWOT and Corporate Finance Report Summary McKesson Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • Burger-In Oy:戦略・SWOT・企業財務分析
    Burger-In Oy - Strategy, SWOT and Corporate Finance Report Summary Burger-In Oy - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate a …
  • Kier Group plc:企業のM&A・事業提携・投資動向
    Kier Group plc - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Kier Group plc Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestmen …
  • Avery Dennison Corporation (AVY):企業の財務・戦略的SWOT分析
    Avery Dennison Corporation (AVY) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and wea …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆